Shareable PDF
COPD
COPD, THORACIC
This one-page PDF can be shared freely online.Shareable PDF Full list of study investigators on the CELEB trial: Royal Brompton Hospital (London): Sara C. Buttery, Winston Banya, Simon Jordan, Samuel V. Kemp, Adam Lewis, Pallav L. Shah, Nicholas S. Hopkinson, Sofina Begum, Michael I. Polkey, Matthew Pavitt, Karthi Srikanthan, Justin Garner, Matthew Hind, Carol Ridge, Sujal Desai, Jennifer Quint. Glenfield Hospital (Leicester): Neil J. Greening, Lorna Latimer, Sridhar Rathinam, Michael C. Steiner. St Bartholomew's Hospital (London): Kelvin Lau, David Waller. Northern General Hospital (Sheffield): Rod Lawson, Sara Tenconi, Kay Housley. Golden Jubilee National Hospital (Glasgow): Alan J.B. Kirk, Rocco Bilancia, Elizabeth Boyd, Julie Buckley, Elaine Matthews.Author contributions: N.S. Hopkinson wrote the study protocol, and obtained ethics approval and authorisation. S.C. Buttery, S.V. Kemp, P.L. Shah, D. Waller, S. Jordan, W. Banya and M.C. Steiner were involved in trial design and revisions of the final protocol. S.C. Buttery, A. Lewis, L. Latimer, K. Housley, E. Boyd and J. Buckley carried out all research visits and randomisation. P.L. Shah, R. Bilancia, S. Jordan, S.V. Kemp, A.J.B. Kirk, K. Lau, S. Rathinam, S. Tenconi and D. Waller carried out the trial procedures and management of the patients involved in the trial. J. Moxham acted as trial committee chair. S.C. Buttery and A. Lewis provided trial oversight, and S.C. Buttery wrote the first draft of the manuscript. N.S. Hopkinson, S.C. Buttery and W. Banya have directly accessed and verified the data report. W. Banya carried out the statistical analysis and production of graphs for the manuscript. All authors contributed to study design, study conduct, interpretation and revising the manuscript. All authors have agreed on the final manuscript and accept final responsibility to submit for publication.This article has an editorial commentary: This study was prospectively registered at the Conflict of interest: D. Waller reports lecture honoraria from PulmonX Ltd, outside the submitted work. N.J. Greening reports grants from GSK, consulting fees from Genentech, lecture honoraria from AstraZeneca and Chiesi, travel support from Chiesi, outside the submitted work. P.L. Shah reports lecture honoraria from PulmonX Ltd, outside the submitted work. R. Bilancia reports lecture honoraria and travel support from Intuitive, outside the submitted work. R. Lawson is a Member of British Thoracic Society COPD Specialist Advisory group, a Member of South Yorkshire Clinical Senate, and a Member of South Yorkshire and Bassetlaw Respiratory Clinical Network, outside the submitted work. All other authors have nothing to disclose.Support statement: This project was funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit Programme (grant reference number PB-PG-1014-35051). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Imperial College London will support the reporting of this manuscript. Trial sponsor representative: Patrik Pettersson, Royal Brompton and Harefield NHS Foundation Trust, Royal Brompton Hospital. The funder of the study had no role in study design, data collection, data analysis, data interpretation or writing of the report. Funding information for this article has been deposited with the 